CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Continue reading

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Continue reading

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Continue reading

Advertisement

CPHI Milan
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Lifecore Biomedical

Advertisement

Solstice
Volume 17, Issue 3

Empowering Drug Delivery at Scale: How Ypsomed’s Platform Approach Advances Self-Injection Globally

From Drug Complexity to Delivery Strategy As pharmaceutical innovation has accelerated over the past several decades, one reality has remained constant: the m...
Continue Reading →
Volume 17, Issue 3

Fragment Screening of Massively-Parallel Ligand Arrays Using the Carterra® Ultra® SPR Platform

Key Highlights• Carterra Ultra® offers the enhanced speed and sensitivity necessary to support Fragment-Based Lead Discovery (FBLD).• Ultra's large ligand array ...
Continue Reading →
Volume 17, Issue 3

AI Teammates Impact on Clinical Research

Clinical research is in a pivotal moment. Over the past two decades, we’ve witnessed extraordinary advances in biology, genomics, and drug discovery. Yet the inf...
Continue Reading →
Volume 17, Issue 3

Safeguarding Potency: Innovative Containment Strategies for HPAPI Manufacturing

The pharmaceutical and biotech industries are undergoing a significant transformation, driven by the rise of precision medicine, biologics, and targeted therapie...
Continue Reading →
Volume 17, Issue 3

Building Contamination Control Strategies for ATMP Manufacturing

Advanced Therapy Medicinal Products (ATMPs) represent a novel class of complex biological products that are at the forefront of scientific innovation and hold gr...
Continue Reading →
Volume 17, Issue 3

In the Pharmaceutical GMP Industry: If Quality Is Everyone’s Responsibility, Is It No One’s Responsibility?

The phrase "Quality is everyone's responsibility" is often misinterpreted in the Pharmaceutical Inspection Cooperation Scheme – Good Manufacturing Practices (PIC...
Continue Reading →
Volume 17, Issue 3

Hygienic Stäubli Robots in Pharmaceutical Packaging Proven Packaging Expertise

How do you package medication sets with four components each, at a rate of 200 per minute, in compliance with pharmaceutical manufacturing requirements? Uhlmann ...
Continue Reading →
Volume 17, Issue 3

How Automation Helps to Accelerate Product Development

Sumeet Dalvi from Emerson explains how advanced automation solutions, paired with unified data strategies, are enabling life sciences organisations to expedite t...
Continue Reading →
Volume 17, Issue 3

The Next Generation of Infuse: Redefining Efficiency, Stability, Speed, and Security

Over the past decade, the pharmaceutical industry has experienced rapid growth in using new and advanced ideas. Prefilled syringes have become a popular method o...
Continue Reading →
Volume 17, Issue 3

The Importance of PRE-Coloured, Biocompatible and Pre-Tested ABS for Medical Device Approval

Biocompatibility is a key property that needs to be complied with by most medical devices to fulfil medical regulations (e.g. EU MDR or US FDA regulatory require...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Tjoapack
Aptar – 08/01/2026